Search - tctmd.com

Displaying 1 - 20 of 1127

Sort: Relevancy | Date

Side Effects of Statins Might Be Overstated: CTT Collaboration

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

February 06, 2026

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

February 04, 2026

Smartwatch Increases AF Diagnosis in Older, High-risk Patients: EQUAL

News Daily News

Smartwatch Increases AF Diagnosis in Older, High-risk Patients: EQUAL

January 23, 2026

JACC Debuts Data Digest on CV Health in the United States

News Daily News

JACC Debuts Data Digest on CV Health in the United States

January 12, 2026

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

AHA Highlights Single-Pill Combo Therapy for Hypertension

News Daily News

AHA Highlights Single-Pill Combo Therapy for Hypertension

December 17, 2025

Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION

News Daily News

Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION

December 16, 2025

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

Pediatric Hypertension On the Rise Globally

News Daily News

Pediatric Hypertension On the Rise Globally

November 28, 2025

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

November 21, 2025

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

News Conference News AHA 2025

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

Yael L. Maxwell

November 13, 2025

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

News Conference News AHA 2025

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

November 12, 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

November 08, 2025

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

News Conference News TCT 2025

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

October 28, 2025

Presentation TCT 2025

TCT 1269: Associations Between AI Based-Quantitative Coronary Plaque Analysis, Calcium Score, and ASCVD Score with Major Adverse Cardiovascular Events: An Observational Study from Piedmont Heart Institute CCTA Registry

Presenter: Venkateshwar Polsani

October 28, 2025

Presentation TCT 2025

TCT 433: Can Major Cardiovascular Adverse Events (MACE) be Predicted? A Systematic Review and Meta-Analysis Exploring the Use of Machine Learning (ML) with Coronary Computed Tomography Angiography (CCTA)

Presenter: Saif Syed

October 27, 2025

Presentation TCT 2025

TCT 534: Circulatory Assist Devices in HFrEF: Assessing 30-Day Major Adverse Cardiovascular Events and Clinical Outcomes

Presenter: Mohamed Elhussain

October 27, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.